Open and rearranged norbornane derived polycyclic cage molecules as potential neuroprotective agents through attenuation of MPP+- and calcium overload-induced excitotoxicity in neuroblastoma SH-SY5Y cells

2020 ◽  
Vol 204 ◽  
pp. 112617 ◽  
Author(s):  
Ayodeji O. Egunlusi ◽  
Sarel F. Malan ◽  
Sylvester I. Omoruyi ◽  
Okobi E. Ekpo ◽  
Vitalii A. Palchykov ◽  
...  
Keyword(s):  
Calcium Overload ◽  
Neuroprotective Agents ◽  
Cage Molecules

Controlling Gas Selectivity in Molecular Porous Liquids by Tuning the Cage Window Size

2019 ◽  
Author(s):  
Benjamin Egleston ◽  
Konstantin V. Luzyanin ◽  
Michael C. Brand ◽  
Rob Clowes ◽  
Michael E. Briggs ◽  
...  
Keyword(s):  
Nmr Spectroscopy ◽  
Chemical Synthesis ◽  
Field Gradient ◽  
Window Size ◽  
Standard Approach ◽  
Porous Solids ◽  
Pulsed Field Gradient Nmr ◽  
Pulsed Field ◽  
Cage Molecules ◽  
Gas Selectivity

Control of pore window size is the standard approach for tuning gas selectivity in porous solids. Here, we present the first example where this is translated into a molecular porous liquid formed from organic cage molecules. Reduction of the cage window size by chemical synthesis switches the selectivity from Xe-selective to CH<sub>4</sub>-selective, which is understood using <sup>129</sup>Xe, <sup>1</sup>H, and pulsed-field gradient NMR spectroscopy.

Controlling Gas Selectivity in Molecular Porous Liquids by Tuning the Cage Window Size

2019 ◽  
Author(s):  
Benjamin Egleston ◽  
Konstantin V. Luzyanin ◽  
Michael C. Brand ◽  
Rob Clowes ◽  
Michael E. Briggs ◽  
...  
Keyword(s):  
Nmr Spectroscopy ◽  
Chemical Synthesis ◽  
Field Gradient ◽  
Window Size ◽  
Standard Approach ◽  
Porous Solids ◽  
Pulsed Field Gradient Nmr ◽  
Pulsed Field ◽  
Cage Molecules ◽  
Gas Selectivity

Control of pore window size is the standard approach for tuning gas selectivity in porous solids. Here, we present the first example where this is translated into a molecular porous liquid formed from organic cage molecules. Reduction of the cage window size by chemical synthesis switches the selectivity from Xe-selective to CH<sub>4</sub>-selective, which is understood using <sup>129</sup>Xe, <sup>1</sup>H, and pulsed-field gradient NMR spectroscopy.

Current Therapeutic Strategies and Perspectives for Neuroprotection in Parkinson’s Disease

2020 ◽  
Vol 26 (37) ◽  
pp. 4738-4746
Author(s):  
Mohan K. Ghanta ◽  
P. Elango ◽  
Bhaskar L. V. K. S.
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Early Diagnosis ◽  
Neurodegenerative Disorder ◽  
Therapeutic Strategies ◽  
Neuroprotective Agents ◽  
Striatal Neurons ◽  
The Status ◽  
Advanced Stages ◽  
Dopaminergic Pathways

Parkinson’s disease is a progressive neurodegenerative disorder of dopaminergic striatal neurons in basal ganglia. Treatment of Parkinson’s disease (PD) through dopamine replacement strategies may provide improvement in early stages and this treatment response is related to dopaminergic neuronal mass which decreases in advanced stages. This treatment failure was revealed by many studies and levodopa treatment became ineffective or toxic in chronic stages of PD. Early diagnosis and neuroprotective agents may be a suitable approach for the treatment of PD. The essentials required for early diagnosis are biomarkers. Characterising the striatal neurons, understanding the status of dopaminergic pathways in different PD stages may reveal the effects of the drugs used in the treatment. This review updates on characterisation of striatal neurons, electrophysiology of dopaminergic pathways in PD, biomarkers of PD, approaches for success of neuroprotective agents in clinical trials. The literature was collected from the articles in database of PubMed, MedLine and other available literature resources.

An Overview of Stroke: Mechanism, In vivo Experimental Models Thereof, and Neuroprotective Agents

2020 ◽  
Vol 21 (9) ◽  
pp. 860-877
Author(s):  
Mohd Muazzam Khan ◽  
Badruddeen ◽  
Mohd Mujahid ◽  
Juber Akhtar ◽  
Mohammad Irfan Khan ◽  
...  
Keyword(s):  
Causes Of Death ◽  
Active Form ◽  
Experimental Models ◽  
Global Cerebral Ischemia ◽  
Channel Blockers ◽  
Neuroprotective Agents ◽  
Decisive Action ◽  
Stroke Mechanism ◽  
Injury Outcomes

Background: Stroke is one of the causes of death and disability globally. Brain attack is because of the acute presentation of stroke, which highlights the requirement for decisive action to treat it. Objective: The mechanism and in-vivo experimental models of stroke with various neuroprotective agents are highlighted in this review. Method: The damaging mechanisms may proceed by rapid, nonspecific cell lysis (necrosis) or by the active form of cell death (apoptosis or necroptosis), depending upon the duration and severity and of the ischemic insult. Results: Identification of injury mediators and pathways in a variety of experimental animal models of global cerebral ischemia has directed to explore the target-specific cytoprotective strategies, which are critical to clinical brain injury outcomes. Conclusion: The injury mechanism, available encouraging medicaments thereof, and outcomes of natural and modern medicines for ischemia have been summarized. In spite of available therapeutic agents (thrombolytics, calcium channel blockers, NMDA receptor antagonists and antioxidants), there is a need for an ideal drug for strokes.

Sign in / Sign up

Export Citation Format

Share Document